Transchem Annual General Meeting
Transchem Limited held its 49th Annual General Meeting on September 05, 2026. Members considered agenda items, including financial statement adoption and related party transaction approvals.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Transchem Limited held its 49th Annual General Meeting on September 05, 2026. Members considered agenda items, including financial statement adoption and related party transaction approvals.
Transchem Limited has executed a Share Purchase Agreement to acquire 100% of Greshma Shares and Stocks Limited for ₹25.91 Crore. The acquired entity becomes a wholly-owned subsidiary.
Transchem Limited has amended its 'Code of Conduct for Prevention of Insider Trading' in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Transchem Ltd reported net profit of ₹3.4 Cr (+240.0% YoY) for Q1 FY27.
Transchem Ltd scheduled a board meeting for August 10, 2026. The meeting aims to consider and approve the June 30, 2026, un-audited financial results.
Transchem Limited has issued a notice for its 49th Annual General Meeting scheduled for September 5, 2026. Key agenda items include adopting financial statements and approving a related party transaction.
Transchem Limited is dispatching notices for its 49th Annual General Meeting scheduled for September 05, 2026. The communication provides web-links for shareholders to access the Annual Report.
Transchem Limited has submitted its 49th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 05, 2026, via video conferencing.
Transchem Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, noting promoter group changes following an internal entity amalgamation.
Transchem Limited allotted 1,20,00,000 warrants to Pishu V. Chainani via a preferential issue. These warrants are convertible into equity shares within 18 months.
Transchem Limited allotted 6.15 crore warrants on a preferential basis, raising ₹461.25 Crore. Warrants are convertible into equity within 18 months, strengthening the company's capital base.
Transchem Limited filed its Annual Secretarial Compliance Report for FY2026. A minor ₹0.01 Crore fine was noted for a marginal delay in board meeting intimation.
Transchem Limited received BSE in-principle approval for a Rs. 61.50 Crore preferential warrant issue. The company will now proceed with consummating the capital raise.
Transchem Limited clarified its ₹115 Crore preferential warrant issue objects for general corporate purposes. Funds will also support strategic acquisitions in the financial services sector.
Transchem Limited confirmed its non-applicability as a Large Corporate for FY 2025-26. The company remains exempt from mandated debt-raising requirements under SEBI framework.
Transchem Limited has re-appointed M/s. L. T. Jadav & Co., Chartered Accountants, as Internal Auditors for the financial year 2026-2027. The decision was approved by the Board of Directors in their meeting on May 05, 2026. The firm has extensive experience in statutory and internal audits since 1985.
Transchem Ltd has scheduled a Board Meeting for May 05, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The trading window for designated persons remains closed from April 01, 2026, until 48 hours after the results are made public.
Transchem Limited (BSE: 500422) has submitted its initial disclosure for FY 2025-26, confirming it is not a 'Large Corporate' as per SEBI's framework. The company reported zero outstanding long-term borrowings as of March 31, 2026, meaning it is not subject to mandatory debt market borrowing requirements.